Current approved therapeutic strategies for IPF and LC treatment.

Idiopathic Pulmonary Fibrosis

Luca TABBÍ, Medical Doctor, Doctor of Medicine, Polyclinic of Modena, Modena, PM, Department of respiratory disease

Linda Manicardi's research works Polyclinic of Modena, Modena (PM) and other places

Stefania CERRI, Assistant Professor, MD, PhD, Università degli Studi di Modena e Reggio Emilia, Modena, UNIMO, Department of Medical and Surgical Sciences for Children and Adults

Small-molecule-mediated OGG1 inhibition attenuates pulmonary

PureTech Presents Data for LYT-100 (Deupirfenidone) Supporting

PDF) Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development

Pulmonary Fibrosis: Unveiling the Pathogenesis, Exploring

Melatonin ameliorates bleomycin-induced pulmonary fibrosis via

Demographic data of the two dead patients during our study

Stefania CERRI, Assistant Professor, MD, PhD, Università degli Studi di Modena e Reggio Emilia, Modena, UNIMO, Department of Medical and Surgical Sciences for Children and Adults

Recent Progress and Future Direction for the Application of

Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based

Advanced In Vitro Lung Models for Drug and Toxicity Screening: The

Linda Manicardi's research works Polyclinic of Modena, Modena (PM) and other places